Shares of BioNTech SE (BNTX) are soaring over 50% in pre-market today, after the company announced rapid progress on COVID-19 vaccine program to address global public health threat. The company's product candidate, BNT162, is a potential first-in-class mRNA vaccine in the worldwide effort against COVID-19.
from RTT - Before the Bell https://ift.tt/2xzwj3d
via IFTTT
No comments:
Post a Comment